Spero Therapeutics Inc (SPRO)
1.25
-0.06
(-4.58%)
USD |
NASDAQ |
Nov 14, 16:00
1.28
+0.03
(+2.40%)
Pre-Market: 08:11
Spero Therapeutics Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.001M |
| September 30, 2023 | 0.22M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 14.18M |
| September 30, 2022 | 6.131M |
| June 30, 2022 | -53.68M |
| March 31, 2022 | 3.814M |
| December 31, 2021 | 50.35M |
| September 30, 2021 | 29.22M |
| June 30, 2021 | 0.168M |
| March 31, 2021 | 4.309M |
| December 31, 2020 | 16.09M |
| September 30, 2020 | 77.22M |
| Date | Value |
|---|---|
| June 30, 2020 | 7.39M |
| March 31, 2020 | 30.19M |
| December 31, 2019 | 5.599M |
| September 30, 2019 | 0.01M |
| June 30, 2019 | 8.963M |
| March 31, 2019 | 1.568M |
| December 31, 2018 | -0.178M |
| September 30, 2018 | 69.90M |
| June 30, 2018 | -0.196M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 74.68M |
| September 30, 2017 | -0.411M |
| June 30, 2017 | -1.161M |
| March 31, 2017 | 43.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-53.68M
Minimum
Jun 2022
77.22M
Maximum
Sep 2020
12.75M
Average
6.131M
Median
Sep 2022
Cash from Financing (Quarterly) Benchmarks
| Arbutus Biopharma Corp | 1.775M |
| Equillium Inc | 0.091M |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | 5.991M |
| iBio Inc | 12.99M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.74M |
| Free Cash Flow | -14.38M |
| Free Cash Flow Per Share (Quarterly) | -0.3474 |
| Free Cash Flow to Equity (Quarterly) | -18.74M |
| Free Cash Flow Yield | -21.48% |